Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane for sedation in cardiac arrest (SEVOCAR)
NCT02201134Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jul 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sevoflurane in cardiac arrest (SCA), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Feasibility of sedation with inhaled sevoflurane at 1 day. Started Jul 2014; status: completed.
02
Drugs
sevoflurane
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02201134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201134.